Morgan Stanley’s Procaps Group, S.A. Ordinary Shares PROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$234 8314
2024
Q4
$234 Hold
100
﹤0.01% 7401
2024
Q3
$220 Hold
100
﹤0.01% 7378
2024
Q2
$251 Hold
100
﹤0.01% 7284
2024
Q1
$290 Sell
100
-100
-50% -$361 ﹤0.01% 7278
2023
Q4
$814 Buy
200
+100
+100% +$291 ﹤0.01% 7229
2023
Q3
$362 Hold
100
﹤0.01% 7340
2023
Q2
$430 Hold
100
﹤0.01% 7389
2023
Q1
$451 Hold
100
﹤0.01% 7448
2022
Q4
$525 Sell
100
-500
-83% -$3.26K ﹤0.01% 7554
2022
Q3
$4K Sell
600
-1,300
-68% -$10.2K ﹤0.01% 7337
2022
Q2
$18K Hold
1,900
﹤0.01% 7032
2022
Q1
$16K Sell
1,900
-81,858
-98% -$737K ﹤0.01% 7244
2021
Q4
$817K Buy
+83,758
New +$817K ﹤0.01% 5222

Morgan Stanley's PROC Position: Q1 2025 in Review

Morgan Stanley sold out of Procaps Group, S.A. Ordinary Shares (PROC) in Q1 2025, closing a stake of 100 shares — an estimated $234 sold.

Morgan Stanley first reported a position in PROC in Q4 2021 and held it in 13 quarters. The position peaked at $817K in Q4 2021. 0 funds tracked by Wall St. Rank hold PROC as of Q1 2025.

  • Morgan Stanley reported no remaining Procaps Group, S.A. Ordinary Shares position as of Q1 2025 after selling out during the quarter.
  • Morgan Stanley sold 100 Procaps Group, S.A. Ordinary Shares shares in Q1 2025, an estimated $234.
  • Morgan Stanley first reported a position in Procaps Group, S.A. Ordinary Shares in Q4 2021 and held it in 13 quarters.
  • Morgan Stanley's Procaps Group, S.A. Ordinary Shares position peaked at $817K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Procaps Group, S.A. Ordinary Shares as of Q1 2025.

Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.